Please login to the form below

Webinar: Maintaining market access through a pandemic, 6 months on

In this webinar, Valid Insight explore market access and how it has evolved through a pandemic over the past 6 months.

In March 2020, Valid Insight brought together a panel of global payers and industry representatives to talk about how the COVID-19 pandemic may affect global market access. Now 6 months on, Valid Insight review what global changes have occurred, and discuss how these changes may have profound market access implications in the future, along with solutions to future-proof.
Join our esteemed speaker panel, consisting of:

  • Leslie Galloway: Expert Adviser at the NICE Centre for Clinical Practice and Chairman of the Ethical Medicines Industry Group (EMIG)
  • Prof. Fabrizio Gianfrate: Professor of Health Economics. Former AIFA member and Director of the Ministry of Health
  • Sue Caleo-Naeyaert: Former Global Head Government Affairs, Policy and Pharmacoeconomics at Fresenius Kabi SwissBioSim

The webinar on 1st October at 2pm (BST) / 9am (EST). Please register here: https://www.validinsight.com/webinars/maintaining-market-access/

Download our white paper: Maintaining Market Access Continuity through a Global Pandemic

29th September 2020

Share

Tags

Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom

Latest content on this profile

Valid Insight are hiring for Consultants in Value Communication (mid to senior levels)
New role available for Consultants in Value Communication with experience in market access writing and value communication.
Valid Insight
Webinar: Maintaining market access through a pandemic, 6 months on
In this webinar, Valid Insight explore market access and how it has evolved through a pandemic over the past 6 months.
Valid Insight
Webinar: How to develop an optimal value story for your product
This webinar is part of the ongoing expert insights series run by Valid Insight
Valid Insight
Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative to alternative treatments for successful market access. In this blog, we summarise the reasons for negative reimbursement decisions in 2017 and discuss common pitfalls manufacturers should avoid.
Valid Insight